English

Major shareholder acquires PHI’s convertible loan from Formue Nord

Report this content

Phase Holographic Imaging (PHI) informs the market that PHI’s largest investor, Altium S.A., has on this day taken over PHI’s outstanding convertible loan from Formue Nord.

The convertible loan was taken by PHI to bridge the consequences of the COVID-19 pandemic in May 2020. The outstanding loan amounts to 17 841 KSEK with the following terms:

  • Conversion rates: 11.90 SEK per new share until May 2, 2023 (last day in the exercise period for warrants of series TO 3) and 15.45 SEK per new share from May 3, 2023, until October 16, 2024.
  • Conversion period: The convertible holder is entitled from the date of payment to October 16, 2024, to convert the loan into shares.
  • Maturity: If the entire loan is not converted, repayment and interest must occur no later than October 16, 2024. The Company has the right to repay all or part of the convertible loan until the due date, after which Altium can accept repayment or request conversion according to the above conversion rates.
  • Interest: The convertibles run at a quarterly interest rate of 3%.

“The acquisition certainly shows Altiums’s long-term commitment as a shareholder but also as our sales and marketing partner,” states PHI CEO Patrik Eschricht.

This disclosure contains information that Phase Holographic is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 26-10-2023 18:00 CET.

For additional information, please contact:
Patrik Eschricht
E-mail: ir@phiab.com
Web: www.phiab.com – Live cell imaging & analysis

Phase Holographic Imaging (PHI) develops instrumentation and software for time-lapse cytometry. The products are used for long-term quantitative analysis of the dynamics of live cells, particularly significant in the research of cancer, as well as in the treatment of inflammatory and autoimmune diseases. The products are sold globally through the company's distributors. The company is based in Lund, Sweden, and in Boston, Massachusetts.

Subscribe

Documents & Links